557 related articles for article (PubMed ID: 24983196)
21. [Management of bullous pemphigoid].
Göbel M; Eming R
Hautarzt; 2019 Apr; 70(4):236-242. PubMed ID: 30874841
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune bullous diseases.
Rye B; Webb JM
Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
[TBL] [Abstract][Full Text] [Related]
23. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
Stanley JR
J Clin Invest; 1989 May; 83(5):1443-8. PubMed ID: 2651476
[No Abstract] [Full Text] [Related]
24. [Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases].
Kasperkiewicz M; Zillikens D
Hautarzt; 2007 Feb; 58(2):115-6, 118-21. PubMed ID: 17237928
[TBL] [Abstract][Full Text] [Related]
25. [Practical management of the most common autoimmune bullous diseases].
Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and classification of pemphigus and bullous pemphigoid.
Kershenovich R; Hodak E; Mimouni D
Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of autoimmune bullous diseases.
van Beek N; Zillikens D; Schmidt E
J Dtsch Dermatol Ges; 2018 Sep; 16(9):1077-1091. PubMed ID: 30179336
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune bullous diseases in childhood.
Sansaricq F; Stein SL; Petronic-Rosic V
Clin Dermatol; 2012; 30(1):114-27. PubMed ID: 22137235
[TBL] [Abstract][Full Text] [Related]
29. The autoimmune bullous diseases.
Wakelin SH; Black MM
J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
[No Abstract] [Full Text] [Related]
30. Autoimmune blistering diseases in children.
Rico MJ
Semin Dermatol; 1995 Mar; 14(1):54-9. PubMed ID: 7742241
[TBL] [Abstract][Full Text] [Related]
31. Blistering disorders: diagnosis and treatment.
Yeh SW; Ahmed B; Sami N; Razzaque Ahmed A
Dermatol Ther; 2003; 16(3):214-23. PubMed ID: 14510878
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic experience in pemphigus and pemphigoid].
Aloi FG; Pippione M
G Ital Dermatol Venereol; 1984; 119(5):357-64. PubMed ID: 6392076
[No Abstract] [Full Text] [Related]
33. [Linear IgA bullous dermatosis: a review].
Ingen-Housz-Oro S
Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
Anhalt GJ; Patel H; Diaz LA
Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
[No Abstract] [Full Text] [Related]
35. When and how to use sulfones in bullous diseases.
Jablonska S; Chorzelski T
Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048
[No Abstract] [Full Text] [Related]
36. Bovine gingival lysate: a novel substrate for rapid diagnosis of autoimmune vesiculo-bullous diseases. A preliminary observation.
Engineer L; Johnson RE; Bhol KC; Ahmed AR
Exp Dermatol; 2000 Aug; 9(4):271-4. PubMed ID: 10949549
[TBL] [Abstract][Full Text] [Related]
37. Targeted Therapies for Autoimmune Bullous Diseases: Current Status.
Amber KT; Maglie R; Solimani F; Eming R; Hertl M
Drugs; 2018 Oct; 78(15):1527-1548. PubMed ID: 30238396
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune bullous diseases: diagnosis and management.
McCuin JB; Hanlon T; Mutasim DF
Dermatol Nurs; 2006 Feb; 18(1):20-5. PubMed ID: 16550892
[TBL] [Abstract][Full Text] [Related]
39. [Blistering autoimmune diseases of childhood].
Goebeler M; Zillikens D
Hautarzt; 2003 Jan; 54(1):14-24. PubMed ID: 12567253
[TBL] [Abstract][Full Text] [Related]
40. Current treatment of autoimmune blistering diseases.
Kasperkiewicz M; Schmidt E
Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
